Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

ENETS Abstract Search

#4164 Diagnostic work-up for neuroendocrine tumors of occult primary at diagnosis: A retrospective monocentric study of 60 cases

Introduction: Neuroendocrine tumors (NET) are sometimes diagnosed with an occult primary. Identifying the primary and ruling-out unknown primary NET (NET-UP) has therapeutic implications.

Conference:

Presenting Author: Roy M

Authors: Roy M, Fodil-Cherif S, Moog S, Lamarta L, Planchard D,

Keywords: neuroendocrine neoplasm, cancer of unknown primary, diagnosis,

#4137 Liquid biopsy as a new tool for the molecular profiling of neuroendocrine neoplasms: The Gustave Roussy experience

Introduction: Molecular profiling (MP) in neuroendocrine neoplasm (NEN) tumor tissue may be useful for precision medicine. Liquid biopsy (LB) is an alternative noninvasive strategy to perform MP.

Conference:

Presenting Author:

Authors: Gagliardi I, Boilève A, Fodil-Cherif S, Moog S, Lamartina L,

Keywords: neuroendocrine tumor, neuroendocrine carcinoma, molecular profile, liquid biopsy, clonal hematopoiesis,

#3646 Thymic neuroendocrine neoplasms – Data from the Czech Neuroendocrine Tumor Registry 2008 – 2022

Introduction: Thymic neuroendocrine neoplasms are very rare, their incidence is only 3% of all NENs a 5% of thymic tumors. On ENETS 2022 Sarah Fodil—Cherif et alt. presented data of 74 patients with thymic NETs from retrospective French study (1988-2020) and their analysis.

Conference:

Presenting Author:

Authors: Sedlackova E, Barkmanova J, Linke Z, Karpianusova T,

Keywords: thymic neoplasms, neuroendocrine tumor,

#3423 MIBG scintigraphy in metastatic neuroblastoma: A retrospective study of 25 cases

Introduction: Meta-iodobenzylguanidine (MIBG) scintigraphy is the first-line functional imaging agent used in neuroblastoma imaging, identifying both the primary tumor and sites of metastatic disease.

Conference:

Presenting Author:

Authors: Ghomari C, Nasri A, Tahraoui Z, Merad S, Medjahedi A,

Keywords: I-MIBG, neuroblastoma, metastasis,